Cargando…
Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C
Background: Evaluation of advanced fibrosis in patients with hepatitis C virus (HCV) infection is used to facilitate decisions on treatment strategy and to initiate additional screening measures. Unfortunately, most studies have predominately Caucasian (Cau) patients and may not be as relevant for A...
Autores principales: | Tama, Maher, Naylor, Paul, Patel, Suhag, Altawil, Johnny, Gulati, Dhiraj, Antaki, Fadi, Mutchnick, Milton G., Ehrinpreis, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807138/ https://www.ncbi.nlm.nih.gov/pubmed/27047767 http://dx.doi.org/10.14218/JCTH.2015.00053 |
Ejemplares similares
-
Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans
por: Reddy, Naveen, et al.
Publicado: (2015) -
Racial Disparity in HCV Demographics and Treatment Between Interferon Era (2002–2003) and Direct Acting Anti-viral Era (2019)
por: Naylor, Paul, et al.
Publicado: (2023) -
Hepatic Sinusoidal Obstruction Syndrome in a Patient With Multiple Myeloma Treated With CyBorD
por: Tariq, Tooba, et al.
Publicado: (2019) -
Demographics of a large cohort of urban chronic hepatitis C patients
por: Siddiqui, Firdous A., et al.
Publicado: (2008) -
Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
por: Naylor, Paul H, et al.
Publicado: (2017)